Alcohol consumption decreases rat hepatic creatine biosynthesis via altered guanidinoacetate methyltransferase activity.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 24256608)

Published in Alcohol Clin Exp Res on November 20, 2013

Authors

Kusum K Kharbanda1, Sandra L Todero, Jordan C Moats, Ryan M Harris, Natalia A Osna, Paul G Thomes, Dean J Tuma

Author Affiliations

1: Department of Biochemistry & Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska; Research Service, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, Nebraska; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska.

Articles by these authors

Alcohol and hepatitis C virus--interactions in immune dysfunctions and liver damage. Alcohol Clin Exp Res (2010) 1.77

Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis. Arthritis Rheumatol (2015) 1.58

Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathway. J Hepatol (2006) 1.39

Recombinant Hep G2 cells that express alcohol dehydrogenase and cytochrome P450 2E1 as a model of ethanol-elicited cytotoxicity. Int J Biochem Cell Biol (2005) 1.34

A comparison of the effects of betaine and S-adenosylmethionine on ethanol-induced changes in methionine metabolism and steatosis in rat hepatocytes. J Nutr (2005) 1.20

Relationship between acetaldehyde levels and cell survival in ethanol-metabolizing hepatoma cells. Hepatology (2002) 1.19

Inhibition of markers of hepatic stellate cell activation by the hormone relaxin. Biochem Pharmacol (2003) 1.18

Microtubules are more stable and more highly acetylated in ethanol-treated hepatic cells. J Hepatol (2005) 1.15

Betaine administration corrects ethanol-induced defective VLDL secretion. Mol Cell Biochem (2009) 1.12

Relaxin receptors in hepatic stellate cells and cirrhotic liver. Biochem Pharmacol (2006) 1.06

Betaine lowers elevated s-adenosylhomocysteine levels in hepatocytes from ethanol-fed rats. J Nutr (2003) 1.06

Involvement of autophagy in alcoholic liver injury and hepatitis C pathogenesis. World J Gastroenterol (2011) 1.06

Chronic ethanol consumption induces global hepatic protein hyperacetylation. Alcohol Clin Exp Res (2009) 1.05

Role of elevated S-adenosylhomocysteine in rat hepatocyte apoptosis: protection by betaine. Biochem Pharmacol (2005) 1.05

WIF-B cells as a model for alcohol-induced hepatocyte injury. Biochem Pharmacol (2004) 1.05

Hybrid malondialdehyde and acetaldehyde protein adducts form in the lungs of mice exposed to alcohol and cigarette smoke. Alcohol Clin Exp Res (2011) 1.05

Ethanol-induced oxidative stress suppresses generation of peptides for antigen presentation by hepatoma cells. Hepatology (2007) 1.04

Methionine synthase. a possible prime site of the ethanolic lesion in liver. Alcohol (2002) 1.02

Microtubule acetylation and stability may explain alcohol-induced alterations in hepatic protein trafficking. Hepatology (2008) 1.02

Ethanol-induced apoptosis in polarized hepatic cells possibly through regulation of the Fas pathway. Alcohol Clin Exp Res (2006) 1.01

Lipopolysaccharide is a cofactor for malondialdehyde-acetaldehyde adduct-mediated cytokine/chemokine release by rat sinusoidal liver endothelial and Kupffer cells. Alcohol Clin Exp Res (2004) 1.00

Role of the proteasome in ethanol-induced liver pathology. Alcohol Clin Exp Res (2007) 0.99

The effect of ethanol on asialoglycoprotein receptor-mediated phagocytosis of apoptotic cells by rat hepatocytes. Hepatology (2002) 0.97

Malondialdehyde-acetaldehyde-adducted protein inhalation causes lung injury. Alcohol (2011) 0.97

Scavenger receptors on sinusoidal liver endothelial cells are involved in the uptake of aldehyde-modified proteins. Mol Pharmacol (2005) 0.97

Autophagy in alcohol-induced liver diseases. Alcohol Clin Exp Res (2012) 0.97

L-Buthionine (S,R) sulfoximine depletes hepatic glutathione but protects against ethanol-induced liver injury. Alcohol Clin Exp Res (2007) 0.97

Alcohol-induced alterations in hepatic microtubule dynamics can be explained by impaired histone deacetylase 6 function. Hepatology (2008) 0.95

Malondialdehyde-acetaldehyde adducts decrease bronchial epithelial wound repair. Alcohol (2005) 0.95

Multilevel regulation of autophagosome content by ethanol oxidation in HepG2 cells. Autophagy (2012) 0.94

Accumulation of proteins bearing atypical isoaspartyl residues in livers of alcohol-fed rats is prevented by betaine administration: effects on protein-L-isoaspartyl methyltransferase activity. J Hepatol (2007) 0.94

Betaine treatment attenuates chronic ethanol-induced hepatic steatosis and alterations to the mitochondrial respiratory chain proteome. Int J Hepatol (2011) 0.93

Adduction of soluble proteins with malondialdehyde-acetaldehyde (MAA) induces antibody production and enhances T-cell proliferation. Alcohol Clin Exp Res (2002) 0.93

Malondialdehyde-acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis. Free Radic Biol Med (2010) 0.92

Effect of chronic ethanol administration on the in vitro production of proinflammatory cytokines by rat Kupffer cells in the presence of apoptotic cells. Alcohol Clin Exp Res (2007) 0.92

Ethanol metabolism results in a G2/M cell-cycle arrest in recombinant Hep G2 cells. Hepatology (2003) 0.92

Effect of ethanol on pro-apoptotic mechanisms in polarized hepatic cells. World J Gastroenterol (2007) 0.90

Malondialdehyde-acetaldehyde (MAA) modified proteins induce pro-inflammatory and pro-fibrotic responses by liver endothelial cells. Comp Hepatol (2004) 0.90

An in vitro method of alcoholic liver injury using precision-cut liver slices from rats. Biochem Pharmacol (2008) 0.89

Transforming growth factor-beta induces contraction of activated hepatic stellate cells. J Hepatol (2004) 0.88

Autoimmune hepatitis induced by syngeneic liver cytosolic proteins biotransformed by alcohol metabolites. Alcohol Clin Exp Res (2010) 0.88

Rat sinusoidal liver endothelial cells (SECs) produce pro-fibrotic factors in response to adducts formed from the metabolites of ethanol. Biochem Pharmacol (2005) 0.88

T cell proliferative responses to malondialdehyde-acetaldehyde haptenated protein are scavenger receptor mediated. Int Immunopharmacol (2003) 0.87

Recent advances in alcohol-induced adduct formation. Alcohol Clin Exp Res (2005) 0.87

Lysosomal leakage and lack of adaptation of hepatoprotective enzyme contribute to enhanced susceptibility to ethanol-induced liver injury in female rats. Alcohol Clin Exp Res (2007) 0.87

Relationship between oxidative stress and hepatic glutathione levels in ethanol-mediated apoptosis of polarized hepatic cells. World J Gastroenterol (2009) 0.87

Impaired methylation as a novel mechanism for proteasome suppression in liver cells. Biochem Biophys Res Commun (2009) 0.87

Formation and immunological properties of aldehyde-derived protein adducts following alcohol consumption. Methods Mol Biol (2008) 0.87

Effect of malondialdehyde-acetaldehyde-protein adducts on the protein kinase C-dependent secretion of urokinase-type plasminogen activator in hepatic stellate cells. Biochem Pharmacol (2002) 0.86

Chronic ethanol consumption results in atypical liver injury in copper/zinc superoxide dismutase deficient mice. Alcohol Clin Exp Res (2009) 0.85

Early growth response-1 contributes to steatosis development after acute ethanol administration. Alcohol Clin Exp Res (2011) 0.85

Exposure of precision-cut rat liver slices to ethanol accelerates fibrogenesis. Am J Physiol Gastrointest Liver Physiol (2010) 0.84

Chronic ethanol treatment impairs Rac and Cdc42 activation in rat hepatocytes. Alcohol Clin Exp Res (2006) 0.84

Ethanol selectively impairs clathrin-mediated internalization in polarized hepatic cells. Biochem Pharmacol (2009) 0.83

Modulation of lysozyme function and degradation after nitration with peroxynitrite. Biochim Biophys Acta (2009) 0.83

Alcohol and liver, 2010. World J Gastroenterol (2010) 0.83

Aldehydes in cigarette smoke react with the lipid peroxidation product malonaldehyde to form fluorescent protein adducts on lysines. Chem Res Toxicol (2005) 0.82

Mechanisms of alcohol liver damage: aldehydes, scavenger receptors, and autoimmunity. Front Biosci (2004) 0.82

Lipid droplet accumulation and impaired fat efflux in polarized hepatic cells: consequences of ethanol metabolism. Int J Hepatol (2012) 0.81

Rab GTPases associate with isolated lipid droplets (LDs) and show altered content after ethanol administration: potential role in alcohol-impaired LD metabolism. Alcohol Clin Exp Res (2013) 0.81

Lysine acetylation induced by chronic ethanol consumption impairs dynamin-mediated clathrin-coated vesicle release. Hepatology (2012) 0.80

Chronic ethanol consumption impairs receptor-mediated endocytosis of MAA-modified albumin by liver endothelial cells. Biochem Pharmacol (2003) 0.80

Relaxin decreases the severity of established hepatic fibrosis in mice. Liver Int (2013) 0.80

Intracellular proteolytic systems in alcohol-induced tissue injury. Alcohol Res Health (2003) 0.79

Relaxin reduces fibrosis in models of progressive and established hepatic fibrosis. Ann N Y Acad Sci (2009) 0.79

Impact of altered methylation in cytokine signaling and proteasome function in alcohol and viral-mediated diseases. Alcohol Clin Exp Res (2012) 0.78

Susceptibility to T cell-mediated liver injury is enhanced in asialoglycoprotein receptor-deficient mice. Int Immunopharmacol (2013) 0.78

Hepatic microtubule acetylation and stability induced by chronic alcohol exposure impair nuclear translocation of STAT3 and STAT5B, but not Smad2/3. Am J Physiol Gastrointest Liver Physiol (2012) 0.78

Alcohol, carcinoembryonic antigen processing and colorectal liver metastases. Adv Exp Med Biol (2015) 0.78

Inhibition of hepatic stellate cell collagen synthesis by N-(methylamino)isobutyric acid. Biochem Pharmacol (2002) 0.77

Increased immunogenicity to P815 cells modified with malondialdehyde and acetaldehyde. Int Immunopharmacol (2008) 0.77

Malondialdehyde-acetaldehyde-haptenated protein induces cell death by induction of necrosis and apoptosis in immune cells. Int Immunopharmacol (2002) 0.77

ATA2-mediated amino acid uptake following partial hepatectomy is regulated by redistribution to the plasma membrane. Arch Biochem Biophys (2002) 0.77

Relaxin receptor expression in hepatic stellate cells and in cirrhotic rat liver tissue. Ann N Y Acad Sci (2005) 0.77

In vitro exposure to malondialdehyde-acetaldehyde adducted protein inhibits cell proliferation and viability. Alcohol Clin Exp Res (2002) 0.76

Cellular steatosis in ethanol oxidizing-HepG2 cells is partially controlled by the transcription factor, early growth response-1. Int J Biochem Cell Biol (2012) 0.76

Cyanamide potentiates the ethanol-induced impairment of receptor-mediated endocytosis in a recombinant hepatic cell line expressing alcohol dehydrogenase activity. Int J Hepatol (2012) 0.76

An annual topic highlight: alcohol and liver, 2011. World J Gastroenterol (2011) 0.75

Halothane potentiates the alcohol-adduct induced TNF-alpha release in heart endothelial cells. BMC Anesthesiol (2005) 0.75

Alcohol-induced defects in hepatic transcytosis may be explained by impaired dynein function. Mol Cell Biochem (2014) 0.75